Rahman, Mahfuzur
Delarosa, Jaclyn
Luies, Sharmin Khan
Alom, Kazi Robiul
Quintanar-Solares, Manjari
Jabeen, Ishrat
Ahmed, Tahmeed
Abu-Haydar, Elizabeth
Sarma, Haribondhu
Funding for this research was provided by:
GlaxoSmithKline (GB) through PATH, Seattle, USA (GR-01542)
Article History
Received: 27 March 2019
Accepted: 12 February 2020
First Online: 24 February 2020
Ethics approval and consent to participate
: The study protocol was reviewed by the PATH Research Determination Committee and determined to not be human subject research. The Institutional Review Board (IRB) of icddr,b (formerly known as International Centre for Diarrhoeal Diseases Research, Bangladesh) provided study approval. IRB of icddr,b consists of the Research Review Committee and Ethical Review Committee. Before study activities in the two study sites commenced, approvals from the Directorate General of Health Services (DGHS) and Directorate General of Family Planning (DGFP) of the Ministry of Health and Family Welfare (MOHFW) and Civil Surgeons in each of the two study districts were obtained. Well-informed written consents were taken from the study participants before interviews were conducted. The privacy, anonymity, and confidentiality of the information provided by the participants were strictly maintained and were not used for any other purpose than this study.
: Not applicable.
: The authors declare that they have no competing interests.